The future of aging is one of strength, clarity, and vitality. XPRIZE Healthspan teams are helping make this a reality.
The Semifinalists in the $101M XPRIZE Healthspan competition have shown exceptional promise in developing therapies aimed at restoring muscle strength, cognitive abilities, and immune function in individuals aged 50–80. Separately, the Finalists in the $10M FSHD Bonus Prize track are advancing innovative treatments specifically targeting muscle function improvement in individuals with Facioscapulohumeral Muscular Dystrophy (FSHD). Teams in both tracks proposed therapeutics bolstered by scientific rigor, clinical partnerships, and pathways toward real-world impact. I could not be more proud.
The Milestone 1 award winners will each receive $250,000 to support the next steps of their work—early stage clinical trials. In our recently released Qualified Team Lookbook, you can explore the innovations of the Top 100 Qualified Teams (the Top 40 are Milestone 1 awardees), and Top 8 Finalists for the FSHD Bonus Prize.
We’ve made incredible strides, and I’m already looking forward to our $10M Milestone 2 awards for XPRIZE Healthspan, where teams will submit finalist applications, de-identified data, enrollment reports, and analyses demonstrating the feasibility and readiness for human subjects research. We’ll announce the official submission deadline soon, but I anticipate it will be April 2026.
These teams are not just advancing science—they’re building a future of health and opportunity for all. And remember, it's not too late to enter the competition with your idea! Email [email protected] with a letter of request for late entry and a one-page summary for administrative review to be part of this transformative work and to be considered for Milestone 2 awarding.
Thank you for being part of this journey, and for committing to a bold new future of human aging.
Dr. Jamie Justice
XPRIZE EVP, Health